Logo image of ARCAD.AS

ARCADIS NV (ARCAD.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:ARCAD - NL0006237562 - Common Stock

35.74 EUR
+0.14 (+0.39%)
Last: 1/5/2026, 11:14:02 AM
Fundamental Rating

4

ARCAD gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 32 industry peers in the Professional Services industry. While ARCAD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ARCAD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ARCAD had positive earnings in the past year.
In the past year ARCAD had a positive cash flow from operations.
Each year in the past 5 years ARCAD has been profitable.
In the past 5 years ARCAD always reported a positive cash flow from operatings.
ARCAD.AS Yearly Net Income VS EBIT VS OCF VS FCFARCAD.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

With a decent Return On Assets value of 6.17%, ARCAD is doing good in the industry, outperforming 71.88% of the companies in the same industry.
The Return On Equity of ARCAD (22.00%) is better than 71.88% of its industry peers.
ARCAD's Return On Invested Capital of 10.90% is fine compared to the rest of the industry. ARCAD outperforms 75.00% of its industry peers.
ARCAD had an Average Return On Invested Capital over the past 3 years of 9.74%. This is in line with the industry average of 10.10%.
The 3 year average ROIC (9.74%) for ARCAD is below the current ROIC(10.90%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.17%
ROE 22%
ROIC 10.91%
ROA(3y)4.63%
ROA(5y)4.14%
ROE(3y)15.99%
ROE(5y)13.31%
ROIC(3y)9.74%
ROIC(5y)9.75%
ARCAD.AS Yearly ROA, ROE, ROICARCAD.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

ARCAD's Profit Margin of 6.17% is fine compared to the rest of the industry. ARCAD outperforms 71.88% of its industry peers.
ARCAD's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 9.64%, ARCAD is in the better half of the industry, outperforming 71.88% of the companies in the same industry.
ARCAD's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.64%
PM (TTM) 6.17%
GM N/A
OM growth 3Y5.13%
OM growth 5Y8.46%
PM growth 3Y-1.46%
PM growth 5Y67.33%
GM growth 3YN/A
GM growth 5YN/A
ARCAD.AS Yearly Profit, Operating, Gross MarginsARCAD.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

4

2. Health

2.1 Basic Checks

ARCAD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ARCAD has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ARCAD has been increased compared to 5 years ago.
The debt/assets ratio for ARCAD has been reduced compared to a year ago.
ARCAD.AS Yearly Shares OutstandingARCAD.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ARCAD.AS Yearly Total Debt VS Total AssetsARCAD.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

ARCAD has an Altman-Z score of 2.49. This is not the best score and indicates that ARCAD is in the grey zone with still only limited risk for bankruptcy at the moment.
ARCAD's Altman-Z score of 2.49 is on the low side compared to the rest of the industry. ARCAD is outperformed by 62.50% of its industry peers.
The Debt to FCF ratio of ARCAD is 5.46, which is a neutral value as it means it would take ARCAD, 5.46 years of fcf income to pay off all of its debts.
ARCAD has a Debt to FCF ratio of 5.46. This is comparable to the rest of the industry: ARCAD outperforms 53.13% of its industry peers.
ARCAD has a Debt/Equity ratio of 1.12. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.12, ARCAD perfoms like the industry average, outperforming 40.63% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF 5.46
Altman-Z 2.49
ROIC/WACC1.72
WACC6.34%
ARCAD.AS Yearly LT Debt VS Equity VS FCFARCAD.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

ARCAD has a Current Ratio of 1.27. This is a normal value and indicates that ARCAD is financially healthy and should not expect problems in meeting its short term obligations.
ARCAD has a Current ratio of 1.27. This is in the better half of the industry: ARCAD outperforms 68.75% of its industry peers.
A Quick Ratio of 1.27 indicates that ARCAD should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.27, ARCAD is doing good in the industry, outperforming 71.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
ARCAD.AS Yearly Current Assets VS Current LiabilitesARCAD.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.7%

3.2 Future

The Earnings Per Share is expected to decrease by -5.28% on average over the next years.
The Revenue is expected to grow by 4.52% on average over the next years.
EPS Next Y9.71%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
EPS Next 5Y-5.28%
Revenue Next Year1.48%
Revenue Next 2Y15.79%
Revenue Next 3Y8.76%
Revenue Next 5Y4.52%

3.3 Evolution

ARCAD.AS Yearly Revenue VS EstimatesARCAD.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
ARCAD.AS Yearly EPS VS EstimatesARCAD.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 23.21 indicates a rather expensive valuation of ARCAD.
ARCAD's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.60, ARCAD is valued at the same level.
ARCAD is valuated rather expensively with a Price/Forward Earnings ratio of 20.80.
Based on the Price/Forward Earnings ratio, ARCAD is valued a bit more expensive than the industry average as 68.75% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.23, ARCAD is valued at the same level.
Industry RankSector Rank
PE 23.21
Fwd PE 20.8
ARCAD.AS Price Earnings VS Forward Price EarningsARCAD.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ARCAD is valued a bit cheaper than the industry average as 71.88% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ARCAD is valued a bit cheaper than the industry average as 68.75% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.83
EV/EBITDA 8.21
ARCAD.AS Per share dataARCAD.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ARCAD has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as ARCAD's earnings are expected to decrease with -7.26% in the coming years.
PEG (NY)2.39
PEG (5Y)N/A
EPS Next 2Y5.64%
EPS Next 3Y-7.26%

6

5. Dividend

5.1 Amount

ARCAD has a Yearly Dividend Yield of 2.81%.
The stock price of ARCAD dropped by -25.05% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 2.67, ARCAD pays a bit more dividend than its industry peers.
ARCAD's Dividend Yield is a higher than the S&P500 average which is at 1.94.
Industry RankSector Rank
Dividend Yield 2.81%

5.2 History

The dividend of ARCAD is nicely growing with an annual growth rate of 31.53%!
Dividend Growth(5Y)31.53%
Div Incr Years6
Div Non Decr Years6
ARCAD.AS Yearly Dividends per shareARCAD.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

37.39% of the earnings are spent on dividend by ARCAD. This is a low number and sustainable payout ratio.
DP37.39%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
ARCAD.AS Yearly Income VS Free CF VS DividendARCAD.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M
ARCAD.AS Dividend Payout.ARCAD.AS Dividend Payout, showing the Payout Ratio.ARCAD.AS Dividend Payout.PayoutRetained Earnings

ARCADIS NV

AMS:ARCAD (1/5/2026, 11:14:02 AM)

35.74

+0.14 (+0.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)10-30 2025-10-30
Earnings (Next)02-19 2026-02-19
Inst Owners58.87%
Inst Owner ChangeN/A
Ins Owners0.46%
Ins Owner ChangeN/A
Market Cap3.23B
Revenue(TTM)1.89B
Net Income(TTM)238.00M
Analysts81.05
Price Target59.93 (67.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.81%
Yearly Dividend0.85
Dividend Growth(5Y)31.53%
DP37.39%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-25.48%
Min EPS beat(2)-36.09%
Max EPS beat(2)-14.86%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-30.78%
Min Revenue beat(2)-35.5%
Max Revenue beat(2)-26.05%
Revenue beat(4)0
Avg Revenue beat(4)-17.6%
Min Revenue beat(4)-35.5%
Max Revenue beat(4)-4.39%
Revenue beat(8)0
Avg Revenue beat(8)-15.75%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.26%
PT rev (3m)-1.08%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.88%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)-5.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-22.22%
Revenue NY rev (1m)-2.17%
Revenue NY rev (3m)-9.76%
Valuation
Industry RankSector Rank
PE 23.21
Fwd PE 20.8
P/S 0.84
P/FCF 12.83
P/OCF 11.18
P/B 2.99
P/tB N/A
EV/EBITDA 8.21
EPS(TTM)1.54
EY4.31%
EPS(NY)1.72
Fwd EY4.81%
FCF(TTM)2.79
FCFY7.8%
OCF(TTM)3.2
OCFY8.94%
SpS42.66
BVpS11.96
TBVpS-4.58
PEG (NY)2.39
PEG (5Y)N/A
Graham Number20.36
Profitability
Industry RankSector Rank
ROA 6.17%
ROE 22%
ROCE 15.97%
ROIC 10.91%
ROICexc 12.52%
ROICexgc 42.24%
OM 9.64%
PM (TTM) 6.17%
GM N/A
FCFM 6.53%
ROA(3y)4.63%
ROA(5y)4.14%
ROE(3y)15.99%
ROE(5y)13.31%
ROIC(3y)9.74%
ROIC(5y)9.75%
ROICexc(3y)11.24%
ROICexc(5y)11.87%
ROICexgc(3y)46.91%
ROICexgc(5y)45.96%
ROCE(3y)13.66%
ROCE(5y)13.67%
ROICexgc growth 3Y8.93%
ROICexgc growth 5Y-10.74%
ROICexc growth 3Y2.55%
ROICexc growth 5Y6.48%
OM growth 3Y5.13%
OM growth 5Y8.46%
PM growth 3Y-1.46%
PM growth 5Y67.33%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF 5.46
Debt/EBITDA 2.4
Cap/Depr 27.21%
Cap/Sales 0.96%
Interest Coverage 8.65
Cash Conversion 56.89%
Profit Quality 105.88%
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z 2.49
F-Score7
WACC6.34%
ROIC/WACC1.72
Cap/Depr(3y)29.56%
Cap/Depr(5y)27.6%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.19%
Profit Quality(3y)159.52%
Profit Quality(5y)558.67%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y9.71%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
EPS Next 5Y-5.28%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.7%
Revenue Next Year1.48%
Revenue Next 2Y15.79%
Revenue Next 3Y8.76%
Revenue Next 5Y4.52%
EBIT growth 1Y14.27%
EBIT growth 3Y20.69%
EBIT growth 5Y17.72%
EBIT Next Year33%
EBIT Next 3Y16.66%
EBIT Next 5Y11.84%
FCF growth 1Y103.35%
FCF growth 3Y1.15%
FCF growth 5Y12.49%
OCF growth 1Y72.35%
OCF growth 3Y2.04%
OCF growth 5Y9.96%

ARCADIS NV / ARCAD.AS FAQ

Can you provide the ChartMill fundamental rating for ARCADIS NV?

ChartMill assigns a fundamental rating of 5 / 10 to ARCAD.AS.


What is the valuation status for ARCAD stock?

ChartMill assigns a valuation rating of 3 / 10 to ARCADIS NV (ARCAD.AS). This can be considered as Overvalued.


Can you provide the profitability details for ARCADIS NV?

ARCADIS NV (ARCAD.AS) has a profitability rating of 7 / 10.


What are the PE and PB ratios of ARCADIS NV (ARCAD.AS) stock?

The Price/Earnings (PE) ratio for ARCADIS NV (ARCAD.AS) is 23.21 and the Price/Book (PB) ratio is 2.99.


What is the financial health of ARCADIS NV (ARCAD.AS) stock?

The financial health rating of ARCADIS NV (ARCAD.AS) is 5 / 10.